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biosynthesis (farnesyl diphosphate synthase, Cyp7b1, 
geranylgeranyl diphosphate synthase, SAA3).
CONCLUSION: Our results provide a novel insight 
into the biological activities of HBx, implicated in the 
inhibition of liver regeneration.
© 2008 WJG. All rights reserved.
Key words: Hepatitis B virus; Hepatitis B X (HBx) protein; 
Liver regeneration; Microarray analysis; Cholesterol; 
Isoprenoid
Peer reviewer: Philip Rosenthal, MD, Professor of Pediatrics 
& Surgery, UCSF, 500 Parnassus Avenue, Box 0136, MU 4-East, 
San Francisco, CA 94143-0136, United States
Sidorkiewicz M, Jais JP, Tralhao G, Morosan S, Giannini 
C, Brezillon N, Soussan P, Delpuech O, Kremsdorf D. Gene 
modulation associated with inhibition of liver regeneration 
in hepatitis B virus X transgenic mice. World J Gastroenterol 
2008; 14(4): 574-581  Available from: URL: http://www.wjgnet.
com/1007-9327/13/574.asp  DOI: http://dx.doi.org/10.3748/
wjg.14.574
INTRODUCTION
The liver has a unique capacity to regenerate after partial 
hepatectomy (PH) or injury[1]. Experimental evidence has 
confirmed that hepatocyte proliferation is responsible for 
liver regeneration following PH, despite the low replication 
rate of  hepatocytes in a normal liver[1]. After a two-third 
partial hepatectomy, hepatocytes switch from a quiescent 
state to a proliferative state and re-enter cell cycle 
division to compensate for the loss of  liver mass. Liver 
regeneration is a multi-step process comprising at least two 
critical points: the immediate early gene phase (priming) 
that mediates the transition of  the quiescent hepatocytes 
to the cell cycle (G1), and progression from G1 to S phase. 
In mice, DNA synthesis peaks at 40-44 h after PH[1].
Numerous growth factors and cytokines regulate 
the regeneration process by providing stimulatory and 
inhibitory signals for proliferation. Tumour necrosis 
factor alpha (TNF-α) and interleukin-6 (Il-6), together 
with their downstream transcription factors Stat-3 and 
nuclear factor kappa B (NF-κB), are the most important 
initiating factors in the regenerative response[1]. TNF-
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Abstract
AIM: To analyze the modulation of gene expression 
profile associated with inhibition of liver regeneration in 
hepatitis B X (HBx)-expressing transgenic mice.
METHODS: Microarray technology was performed 
on liver tissue obtained from 4 control (LacZ) and 
4 transgenic mice (HBx-LacZ), 48 h after partial 
hepatectomy. The significance of the normalized log-
ratios was assessed for each gene, using robust 
t -tests under an empirical Bayes approach. Microarray 
hybridization data was verified on selected genes by 
quantitative PCR.
RESULTS: The comparison of gene expression patterns 
showed a consistent modulation of the expression 
of 26 genes, most of which are implicated in liver 
regeneration. Up-regulated genes included DNA repair 
proteins (Rad-52, MSH6) and transmembrane proteins 
(syndecan 4, tetraspanin), while down-regulated genes 
were connected to the regulation of transcription 
(histone deacetylase, Zfp90, MyoD1) and were involved 
in the cholesterol metabolic pathway and isoprenoid 
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α-induced hepatocyte proliferation has been shown to 
involve the small GTPases (Ras and RhoA) necessary 
for cell cycle progression by stimulating the degradation 
of  Cdk inhibitors (p21Cip and p27Kip1)[2]. The initiation 
factors governing liver regeneration partially overlap with 
regulators of  the hepatic acute phase response (APR), 
which results in dramatic changes in the expression 
of  acute phase response proteins following PH[3]. 
Hepatocyte growth factor (HGF) and transforming 
growth factor alpha (TGFα) further stimulate cell cycle 
progression, DNA synthesis and cell proliferation. Finally, 
TGF-β and activin suppress cell growth and terminate 
liver regeneration at a fixed point[1]. Recently, a large scale 
gene expression analysis, based on cDNA microarray 
technology, has provided a unique opportunity to 
elucidate the expression pattern throughout the course 
of  liver regeneration[4-6], and the priming phase of  liver 
regeneration in mice[7]. 
In a previous report, we showed that hepatitis B 
virus (HBV) X protein (HBx) inhibits liver regeneration 
after PH in HBx-expressing transgenic mice, and also 
demonstrated a paracrine inhibitory effect of  HBx on 
liver cell proliferation[8]. HBx exhibits pleiotropic effects 
that modulate cell responses to genotoxic stress, protein 
degradation, cell viability and signalling pathways[9]. HBx 
has been shown to enhance transcription in the cytoplasm 
by activating various signal transduction cascades such as 
Ras/Raf  mitogen-activated protein kinase and Src kinases, 
as well as in the nucleus through transcription factors like 
AP-1, AP-2 and NF-κB. Several studies have identified 
possible cellular targets of  HBx, including members 
of  the cyclic-AMP response element binding protein 
(CREB)/activating transcription factor (ATF) family, 
the TATA-binding protein, RNA polymerase subunit 
RPB5, the UV-damaged DNA-binding protein and the 
replicative senescence p55sen[9,10]. HBx has been shown to 
interact with p53 and inhibit its function, but it may also 
induce apoptosis via p53-dependent and independent 
mechanisms[9]. Furthermore, it has been demonstrated that 
mutations identified in HBx-encoding sequences in the 
tumour cells of  HCC can markedly modify the biological 
activity of  HBx, and possibly favour cell transformation[11]. 
It has been shown that the HBx protein participates in 
the development of  hepatocellular carcinoma (HCC) in 
HBV infected patients[12]. Indeed, HBx protein can induce 
HCC in certain transgenic mice and may, under certain 
conditions, cooperate in vitro with Myc or Ras oncogene[13]. 
However, the mechanisms involved in HBx-mediated HCC 
remain obscure.
In the present study, we analyzed further the impact of  
HBx on gene expression profile in the liver of  transgenic 
mice, following PH. For this purpose, we employed HBx-
expressing transgenic mice mentioned above, and adopted 
a transcriptome approach to analyse gene expression 
modulation, 48 h after PH. We observed that impaired 
DNA synthesis and reduction in liver mass in HBx-
transgenic mice was associated with a weaker expression 
of  genes involved in the cholesterol and nonsterol 
isoprenoid pathways as well as in impaired expression of  
serum amyloid A.
MATERIALS AND METHODS
Source of RNA
Two groups of  mice (the same as described previously[8]) 
were used as liver RNA source. HNF1-LacZ transgenic 
mice carrying the nls-LacZ gene driven by the hepatocyte 
nuclear factor (HNF-1) promoter acted as controls. Test 
animals AX16/HNF1-LacZ double transgenic mice, were 
generated by crossing homozygous AX16 transgenic mice 
carrying ORF HBx linked to the promoter/enhancer of  
human anti-thrombin Ⅲ gene, with HNF1-LacZ transgenic 
mice. PH was performed on 21-35 d old LacZ and HBx-
LacZ (with confirmed expression of  HBx) transgenic mice. 
Frozen liver tissue obtained from 4 control (LacZ) and 4 
treated (HBx-LacZ) mice was pulverized in liquid nitrogen, 
48 h after partial hepatectomy. Total RNA extraction was 
performed using RNAble (Eurobio), according to the 
manufacturer’s instructions and purified by RNeasy kit 
(Qiagen) followed by on-column DNase digestion (RNase-
free DNase set). Only RNAs with an absorbance ratio of  
260/280 over 1.9 and intact ribosomal 28S and 18S rRNA 
bands, evaluated by 1% agarose gel electrophoresis, were 
utilized for the microarray study.
Microarray assay
The aminoallyl indirect labelling method was used to obtain 
Cyanin-3 (Cy-3) or Cy-5 labelled cDNA. Briefly, 20 µg of  
total RNA and 5 µg of  oligo-dT primers were incubated at 
70℃ for 10 min and snap-cooled in ice, in order to generate 
aminoallyl-labelled cDNA. Reverse transcription was then 
performed by adding 0.5 mmol/L dATP, dCTP, dGTP, 
0.3 mmol/L dTTP, 0.2 mmol/L aminoallyl-dUTP (aa-
dUTP), 400 U SuperScript Ⅱ, 10 mmol/L DTT, and 1 × 
first strand buffer. This mixture was incubated at 42℃. 
After RNA hydrolysis (1 U of  RNaseH at 37℃ for 15 min), 
unincorporated aa-dUTP was removed by the QIAquick 
PCR purification kit (Qiagen). The resulting aminoallyl 
-cDNAs were diluted in 0.1 mol/L sodium carbonate (pH 
9.0) and coupled with 100 µg of  Cy-3 or Cy-5 monoreactive 
dye (Amersham), prepared in dimethyl sulfoxide (DMSO) 
for 1 h. Cy3 and Cy5 labelled cDNA targets were 
concentrated in a Microcon filter device (Millipore) and 
suspended in 15 µL of  hybridization buffer (0.7% SDS, 
70% formamide in 3.6 × Denhardt solution). The cDNA 
microarray consisting of  5376 mice and rat cDNA spotted 
onto glass slides (Functional Genomic Service, CEA) was 
prehybridized in buffer containing: 3.5 × sodium chloride-
sodium citrate buffer (SSC), 1% Bovine Serum Albumin 
(BSA) and 0.1% sodium dodecyl sulfate (SDS) for 1 h at 
50℃. For each experiment, test cDNA was mixed with 
control cDNA, labelled with Cy3. Mixed, labelled cDNA, 
after preheating to 42℃ in hybridization buffer, was overlaid 
on dried glass cDNA array and incubated overnight at 42℃. 
After hybridization, the slides were washed once in 2 × 
SSC/0.2% SDS buffer and twice in 0.2 × SSC buffer, and 
dried by centrifugation.
Microarray analysis
For each slide, the fluorescent images of  hybridized 
microarray were scanned with a Gene Pix 4000B scanner. 
Image analysis was performed using a Gene Pix Pro 
40 054 to quantify the arrays. Spots flagged automatically 
by Genepix or by visual inspection of  the array scans 
were excluded from the analysis. Global normalization 
was applied to correct the artefacts caused by different 
incorporation rates or scanner settings for two dyes. 
Scatter plots in a log scale were performed to visualize fold 
changes between two channels by plotting Cy5 intensity 
against Cy3 intensity. Normalization steps were performed 
using Bioconductor array packages[14]. After removal of  
the background, we normalized the log2 of  the cy5/cy3 
ratio using a print-tip loess approach[15]. For each gene, 
the average of  the normalized log-ratios was computed 
and the significance was assessed using robust t-tests 
under an empirical Bayes approach[16] as implemented 
in the limma package. P-values were then corrected by 
the FDR approach[17] to take account of  test multiplicity. 
Differentially expressed genes were considered to be those 
with a false discovery rate (FDR) of  less than 5% and an 
expression ratio > 1.4.
Real-time PCR
In order to verify microarray hybridization data, real-
Time PCR was performed using a Light Cycler rapid 
thermal system (Roche Diagnostics). Random cDNA 
was transcribed from 10 µg total RNA with 400 U of  
Superscript Ⅱ in the presence of  1 µg random primers, 
according to the manufacturer’s instructions. All PCR 
experiments were car ried out on the same cDNA 
preparation. Reactions were performed according to the 
manufacturer’s instructions in a 20 µL volume containing 
2 µL of  10-fold diluted cDNA, 0.5 µmol/L of  primers, 
and an MgCl2 concentration optimized between 2 and 
4 mmol/L. A typical protocol included 10 min of  initial 
denaturation followed by 40 cycles of  95℃ denaturation 
for 20 s, annealing at 53℃-56℃ for 15 s and a 72℃ 
extension for 5-12 s (depending on the PCR product). 
For each set of  primers, a template without reverse 
transcription was amplified as a negative control. The 
details of  primer sequences and amplification conditions 
are summarized in Table 1. The quantification of  gene 
expression was based on a standard curve prepared from 
gene-specific, purified PCR product (PCR clean-up kit, 
Macherey-Nagel). The specificity of  each PCR product 
was controlled by a melting curve analysis and subsequent 
agarose gel electrophoresis of  the PCR product. For each 
experiment, relative concentrations were obtained after 
normalization with β-actin values. Calculation of  the 
ratio of  each mRNA expression was based on the relative 
concentration of  specific cDNA found by RT-PCR in 
samples originating from control and HBx-expressing 
livers.
RESULTS
Microarray analysis of gene expression in the liver of 
HBx-transgenic mice after partial hepatectomy
As previously reported, HBx expression inhibits liver 
regeneration after PH in AX16/HNF1-LacZ transgenic 
mice, by a combination of  intracellular and paracrine 
effects[8]. In the present study, we investigated, using 
microarray analysis consisting of  5376 murine genes, the 
impact of  HBx expression on gene expression profile, 
48 h after partial hepatectomy to analyze any changes in 
gene expression which may be involved in the observed 
inhibition of  liver regeneration in HBx transgenic mice. 
This time point of  gene expression analysis was chosen 
in order to determine alterations in gene expression 
associated with the DNA synthesis phase[1]. In addition, 
BrdU incorporation analysis performed on SCID mice 
transplanted with HBx-expressing hepatocytes, 48 h after 
partial hepatectomy, had indicated a marked (5.5-fold) 
reduction in the cellular DNA synthesis[8].
RNAs isolated from the livers of  four HBx-LacZ 
mice were labelled separately with Cy5, and RNAs from 
the livers of  four LacZ mice were mixed together and 
labelled with Cy3 as the reference. Thus, the expression 
profile of  each of  the four tested RNA was compared 
with the expression of  control RNA by the microarray 
assay (performed in duplicate). 82% of  the clones spotted 
Table 1  Primer’s sequence and PCR conditions used for the microarray results validation
MSH6: DNA mismatch repair protein 6.
Name of gene Sequences of forward (F) and 
reverse (R) primers
Source of primers PCR product (bp) T anneling (℃) Mg2+ (mmol/L)
Serum amyloid A3 F: TCAGCACATTGGGATGTTTAGG UniSTS: 219434 206 53 3
R: CAGAGGACTCAAGAGCTGACCA
Creatine kinase muscle F: CCTCCTGGAAGTCCAATCAT UniSTS: 159603 150 53 3
R: GGCCATCACGGACTTTTATT
Peroxiredoxin 1 F: GAGCAGCCAGAAGAAACTCTTG UniSTS: 144118 153 53 3
R: AGAAGATTGGTCTGCCCAAAA
Retinoblastoma-like 2 F: TGGCTGAGTCCTGTAACAAC UniSTS: 162222 374 53 2
R: CCAACACCTTTCTGAGGC
Interleukin-6-receptor, 80-kD F: AAGCAGCAGGCAATGTTACC [18] 120 55 3
R: CATAAATAGTTCCCAGTGTCG
DNA mismatch repair protein MSH6 F: ATATGTCCTAGGCGCACACAAA UniSTS: 211063 208 56 4
R: CTAGCATACTCAGGCATGCGAC
Peroxisome proliferator-activated 
receptor-α
F: CATCGAGTGTCGAATATGTGG [19] 172 55 4
R: GCAGTACTGGCATTTGTTCC
β-actin F: CGTGACATTAAGGAGAAGCTGTGC [20] 374 53 2
R: CTCAGGAGGAGCAATGATCTTGAT
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on the microarray revealed hybridization signals, and 
the data shown in Tables 2 and 3 was obtained after the 
elimination of  genes that did not comply with the criteria 
for expression, normalization and statistical analysis (see 
Material and Methods). In order to validate the microarray 
analysis, real-time PCR was performed on selected 
genes for which the expression was found to be up- or 
down-regulated or unmodified in LacZ-HBx mice when 
compared with LacZ mice. As shown in Table 4, the RT-
PCR results were similar to the data obtained from cDNA 
microarrays; we therefore did not perform RT-PCR on all 
the genes listed in Tables 2 and 3.
As shown in Table 2, the majority of  the up-regulated 
genes in HBx-expressed transgenic mice corresponded 
to the expression of  DNA repair and transmembrane 
proteins. RAD52 is responsible for DNA double-strand 
break repair and mitotic recombination and MSH6 for 
DNA mismatch repair[21]. The transmembrane protein 
genes implicated in focal adhesion (syndecan 4), viral 
internalization (CD209), transport of  protein between 
the medial-and trans-Golgi compartment (Golgi SNAP 
receptor) and in interactions with beta-1 integrin 
(transmembrane 4 superfamily member 2) were found to 
be up-regulated. In addition, changes in the expression of  
the epidermal growth factor and Aven, a caspase inhibitor, 
were also observed.
Genes whose expression was found to be down-
regulated in the liver of  HBx-expressed transgenic 
mice (Table 3) consisted of  two main classes: those 
connected to the transcription control, such as Myogenic 
differentiation1, Zinc finger protein 90 and Histone 
deacetylase 10 (HDAC 10), and genes involved in cell 
metabolism, such as serum amyloid A3 (SAA3), creatine 
kinase, pepsinogen C, aldolase A, glutathione S-transferase 
and phospholipase A2. A subclass of  down-regulated 
genes, connected with cholesterol metabolism and 
isoprenoid synthesis, such as farnesyl diphosphate synthase 
(FPPS), geranylgeranyl diphosphate synthase (GGPPS) 
and Cyp7 were also observed. In the group of  genes that 
was found to be down-regulated in the liver of  HBx-
transgenic mice, we observed several genes like SAA3, 
aldolase A, creatine kinase, phospholipase A2 that have 
been reported elsewhere as up-regulated during the course 
of  liver regeneration[22-24].
Interestingly, down-regulation of  histone deacetylase 
and up-regulation of  DNA repair genes (Rad52 and MSH6) 
Table 2  Upregulated genes in HBx-LacZ transgenic mice 48 h after partial hepatectomy
Abbreviations: RAD52: DNA double-strand break repair and recombination protein; DC-SING: Dendritic Cells-specific intercellular adhesion molecule 3-grabbing 
nonintegrin.
Gene name (Abbreviation) Unigene ID    GB Acc. Fold difference 
HBx-LacZ/LacZ
P  value                  Function
Aven: caspase activation inhibitor Mm.292041     BF662037 1.50 0.030 Caspase inhibitor
RAD52 homolog Mm.149     U12135 2.14 0.035 DNA repair/double-strand break
Mismatch repair protein MSH6 Rn.16755     XM345633 1.51 0.009 DNA repair/mismatch
Epidermal growth factor Rn.6075     NM012842 1.40 0.014 Growth factor
DC-SING (CD209) Mm.32510     NM133238 1.40 0.009 Transmembrane protein/Cell adhesion
Leucyl-tRNA synthetase Hs.432674     NM020117 1.41 0.009 Metabolism/protein synthesis
Syndecan 4 Mm.3815     BC005679 1.42 0.014 Transmembrane protein/Focal adhesion
Transmembrane 4 superfamily member Mm.18590     BC050153 1.45 0.009 Tetraspanin interacting with beta-1 integrin
Golgi SNAP receptor complex member 2 Rn.13518     BC061994 1.42 0.011 Transmembrane protein/Vesicular transport of Golgi
Table 3  Downregulated genes in HBx-LacZ transgenic mice 48 h after partial hepatectomy
Gene name (Abbreviation) Unigene ID GB Acc. Fold difference 
HBx-LacZ/LacZ
P  value Function
Serum amyloid A3 (Saa3) Mm.14277 X03479            -1.95 0.016 Acute phase response protein 
cholesterol transport
Cadherin 16 (Cdh 16) Mm.19423 AF016271            -2.64 0.010 cell recognition protein
Creatine kinase (Ckm) Mm.2375 AI325205            -1.65 0.040 ATP synthesis
Glutathione S-transferase, pi2 (Gstp2) Mm.299292 AI325120            -1.85 0.043 Detoxification and drug metabolism
Progastricsin ( pepsinogen C) (Pgc) Mm.22957 AK008959            -1.73 0.009 Digestion enzyme
Phospholipase A2 group 1B (Pla2g1b) Mm.20190 AI327450            -1.58 0.016 Digestion enzyme
Tripsin Ⅱ precursor (Try2) Mm.301947 AI386046            -1.54 0.014 Digestion enzyme
Farnesyl diphosphate synthase (Fdps) Mm.39472 W76783            -1.98 0.020 Enzyme of cholesterol pathway
Cytochrom P450, 7b1 (Cyp7b1) Mm.278588 U36993            -1.61 0.009 Enzyme of cholesterol pathway
Geranylgeranyl diphosphate synthase 1 (Ggps 1) Mm.148039 AB016044            -1.41 0.034 Enzyme of cholesterol pathway
Aldolase1, A isoform (Aldo 1) Mm.275831 AI327494            -3.35 0.015 Enzyme of glycolysis pathway
Peptidylglycine alpha-amidating monooxygenase Mm.5121 AI323455            -1.73 0.029 Posttranslational modification
Mouse integrase gene (IN) NF X52622            -1.43 0.021 Replication
Myogenic differentiation1 (MyoD1) Mm.1526 M84918            -1.52 0.032 Transcription
Zinc finger protein 90 (Zfp 90) Mm.295582 X79828            -2.06 0.040 Transcription
Histone deacetylase 10 (Hdac 10) Mm.346413 AI323 456            -3.73 0.014 Transcription
Prion protein (Prnp) Mm.648 M13685            -1.40 0.021 CNS protein
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observed in our study in HBx-transgenic mice after PH 
have, in agreement with other reports, similar effect on the 
cell cycle by inducing cell cycle arrest[25-28]. Furthermore, 
it has previously been reported that HBx expression may 
interfere with nucleotide excision repair mechanisms[29,30] 
and interact with the DNA repair protein[31,32].
In the next subsections we will focus on selected 
modulated genes implicated in cholesterol regulation and 
discuss their possible impact on the inhibition of  liver 
regeneration.
Modulation of serum amyloid A expression and liver
regeneration
SAA3 is a multifunctional protein involved in acute 
phase response, inflammation, and cholesterol transport. 
However, the precise function of  SAA in liver regeneration 
is unclear. The physiological transient induction of  SAA 
appears to be indispensable for the precise regeneration 
rate after PH[3]. To investigate whether HBx expression 
was able to completely or partially inhibit SAA3 expression 
during PH, real time RT-PCR was performed on liver 
biopsies obtained at the time of  PH (T0) and 48 h 
later from two LacZ or HBx-LacZ transgenic mice. As 
expected, in the control LacZ animals, a marked increase 
in SAA expression (more than 10-fold) was observed 48 h 
after PH as compared to T0 (Figure 1A). By contrast, in 
HBx-LacZ mice, PH was not associated with an increase 
in the expression of  SAA3 transcript. Thus, HBx induces 
complete inhibition of  SAA response during PH. This may 
constitute an important factor involved in the impaired 
liver regeneration previously observed in these animals.
Regulation of  SAA expression during the acute 
phase response depends on hepatic mitogens (Il-6, IL-1, 
TNF-α)[3]. As the expression of  these cytokines is not 
significantly modified by HBx 48 h after PH, they are 
probably not implicated in the observed inhibition of  
SAA3 transcription in HBx-LacZ transgenic mice. To 
define whether any modulation of  the expression of  Il-6 
receptor (IL-6R), not incorporated in our microarray, is 
related to the inhibition of  SAA expression in HBx-LacZ 
mice, we used RT-PCR assay to determine the expression 
of  IL-6R in LacZ and HBx-LacZ transgenic mice, at the 
time of  PH and 48 h later. As shown in Figure 1B, prior 
to PH, no difference in IL-6R expression was observed in 
HBx-LacZ mice compared to control mice. By contrast, 
48 h after PH there was greater than 3-fold up-regulation 
in HBx-LacZ mice as compared to controls. These 
findings suggest that HBx is able to modulate Il-6 receptor 
expression in association with a factor activated during 
PH and confirms that the lack of  SAA response after 
PH in HBx-expressing transgenic mice is independent of  
cytokine activity.
Table 4  Results from RT-real time PCR 48 h after PH for selected genes
Gene Mice1                    RT-real time PCR Microarrays fold difference HBx-LacZ/LacZ
Relative value2 Fold difference HBx-LacZ/LacZ
SAA3 LacZ    0.37 ± 0.41                         -10.9                                    -2.00
HBx-LacZ    0.03 ± 0.02
Creatine Kinase LacZ    1.36 ± 1.29                           -1.6                                    -1.65
HBx-LacZ    0.87 ± 0.91
MSH6 LacZ    1.08 ± 0.64                            1.5                                     1.50
HBx-LacZ    1.62 ± 0.64
Rb2 LacZ    0.47 ± 0.15                            1.2                                     1.20
HBx-LacZ    0.59 ± 0.23
Peroxiredoxin LacZ    0.08 ± 0.02                            1.5                                     1.40
HBx-LacZ    0.12 ± 0.08
SAA3: Serum Amyloid A3; MSH6: DNA mismatch repair protein 6; Rb2: Retinoblastoma like-2. 1Four animals in control (LacZ) group and four animals in treated 
(HBx-LacZ) group; 2for each experiment relative values were obtained after normalization with beta actin expression.
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Figure 1  Expression levels of SAA3 (A) and IL-6R (B) transcripts in livers 
obtained from LacZ and HBx-LacZ transgenic mice. RNA was isolated before (T0) 
and 48 h after (T48) partial hepatectomy from the liver of two HBx-expressing 
(HBx-LacZ) and two control (LacZ) transgenic mice. The level of transcript 
expression was analyzed by quantitative RT-PCR and expressed as relative ratios 
after normalization with β actin values. The means of the relative ratio values 
and standard error were obtained from at least two independent experiments 
performed in duplicate.
578          ISSN 1007-9327       CN 14-1219/R     World J Gastroenterol      January 28, 2008    Volume 14     Number 4
www.wjgnet.com
SAA3
IL-6R
Impaired expression of isoprenoid pathway and
peroxisome proliferator-activated receptor-α
We observed that after PH of  HBx-transgenic mice, the 
expression of  enzymes implicated in the isoprenylation 
biosynthesis (FPPS and GPPS, and to a lesser extent 
HMG-CoA syn thase ) was r educed in the l ive r. 
Peroxisome proliferator-activated receptor-α (PPARα) is 
a transcription factor that controls lipid metabolism and 
glucose homeostasis. PPARα regulates the expression 
of  enzymes implicated in isoprenoid synthesis, and its 
role in liver regeneration after PH was demonstrated via 
mechanisms involving prenylation of  small GTPases Ras 
and RhoA independent of  TNF-α and IL-6 activation[33-35]. 
In addition, it was observed that PPARα is involved in the 
expression of  FPPS and HMG-CoA synthase after PH[33]. 
Thus, we wanted to investigate whether the decrease in 
the expression of  enzymes implicated in isoprenylation 
observed in HBx-transgenic mice can be explained by a 
decrease in PPARα expression. We used RT-PCR to assess 
PPARα expression in LacZ and HBx-LacZ transgenic 
mice, both at the time of  PH and 48 h later. At the time 
of  PH, a 60% decrease in the expression of  PPARα gene 
was observed in HBx-LacZ compared to LacZ transgenic 
mice (Figure 2). It has been reported that the absence 
of  PPARα expression in mice contributes to impaired 
liver regeneration[36]. As previously reported, there is 
a general decrease in PPARα expression after PH [37]. 
In accordance with the microarray data, there was no 
difference in PPARα expression between LacZ and HBx-
LacZ transgenic mice, 48 h post PH. Thus, the reduced 
expression of  PPARα before PH may be involved in the 
inhibition of  liver regeneration in HBx-LacZ transgenic 
mice.
DISCUSSION
In the present study, we used liver biopsies of  HBx-
expressing transgenic mice, 48 h after partial hepatectomy, 
to assess the factors implicated in the inhibition of  liver 
regeneration in HBx-transgenic mice, by determining the 
alterations in mRNA profile. By that means, we extended the 
results obtained in in vivo studies, demonstrating inhibition 
of  liver regeneration by HBx-expression in HBx-transgenic 
mice[8]. The present study demonstrates the influence 
of  altered expression of  genes involved in transcription 
control, DNA reparation, cholesterol metabolic pathway 
and isoprenoid biosynthesis in the reduction of  liver mass 
observed in HBx-transgenic mice[8].
Although the data is controversial, it has been shown 
that HBx may up-regulate the expression of  p21waf1/cip1 
and prolong G1→S transition[38,39]. A recent study on liver 
regeneration performed on transgenic mice showed that 
HBx can block G1/S transition, and so cause the lower 
liver mass restoration[40]. In this context, we showed that 
HBx down-regulated HDAC10 and up-regulated DNA 
repair gene (Rad52 and MSH6) expression, which may 
have a similar impact on the cell cycle. Indeed, HDAC 
inhibition causes cell cycle arrest due to an increase in the 
expression of  p21 WAF1/Cip1 and Rb[25,26,41,42]. Moreover, 
it has been reported that Rad52 over-expression affects cell 
cycle regulation by delaying the exit from G1[27], and that 
MSH6 protein induces apoptosis by activation of  p53[28]. 
Thus, one of  the possible mechanisms that has emerged 
from our study is in accordance with previously reported 
activity of  HBx, inhibition of  cell cycle progression 
throughout the modulation of  pathways implicated in 
DNA repair and transcription control.
During regeneration induced by tissue loss, a complex 
of  growth factors and cytokines induce hepatocyte 
progression from G0 to cell cycle to restore the original 
liver mass. At the same time, Il-6, IL-1 and TNF-α, known 
to be hepatic mitogens, induce the acute-phase response 
(APR)[3,43]. During APR, the hepatic biosynthesis of  SAA 
is up-regulated by proinflammatory cytokines, and the 
circulating concentration of  SAA can increase up to 1000 
fold. SAA is induced transiently and returns to its normal 
low basal level within 72-96 h of  the initial stimulus[44]. It 
has been reported earlier that the mRNA for APR protein 
such as serum amyloid A increases dramatically during 
liver regeneration[45]. When we analyzed the changes in the 
mRNA profile in liver 48 h after PH we also observed a 
greater than 10-fold increase in the level of  SAA mRNA, 
but only in the control mice. SAA expression level in HBx-
transgenic mice 48 h after PH remained unchanged (even 
slightly lower) when compared to T0. Although the exact 
function of  SAA is still unclear, the physiologic transient 
induction of  SAA appears to be indispensable for proper 
regeneration after PH. Thus, the lack of  SAA response 
in HBx-transgenic mice after PH may constitute an 
alternative factor in the impaired regeneration.
The act iv i ty of  HMG-CoA synthase, farnesy l 
pyrophosphate synthase and geranylgeranyl pyrophosphate 
synthase was found to be ind ispensab le for the 
isoprenylation process and the subsequent cell cycle 
progression and cell proliferation[33,34]. Furthermore, 
FPPS and GGPPS are implicated in cell cycle progression 
via their association with the isoprenylation process of  
GTPases Ras and RhoA proteins[33,34,46]. In addition, 
PPARα plays an important role in regulating lipid 
homeostasis. Studies of  PPARα null mice have revealed 
the importance of  PPARα in the hepatic lipid metabolism 
and liver regeneration[33,36]. Based on our cDNA microarray 
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Figure 2  Expression levels of PPARα transcripts in the liver of two HBx-expressing 
(HBx-LacZ) and two control (LacZ) transgenic mice, before (T0) and 48 h 
after (T48) partial hepatectomy. The level of transcript expression was analyzed 
by quantitative RT-PCR and expressed as relative ratios after normalization with 
β actin values. The means of the relative ratio values and standard error were 
obtained from at least two independent experiments performed in duplicate.
PPARα
results we determined that after PH of  HBx-transgenic 
mice the expression level of  these enzymes in the liver is 
down-regulated. As shown in previous studies, inhibition 
of  enzymes involved in cholesterol and isoprenoid 
synthesis leads to the upregulation of  cdk inhibitors, 
reduction in cdk, hypophosphorylation of  Rb, followed 
by cell cycle arrest in G1[47,48]. Thus, the tempered liver 
regeneration in HBx-transgenic mice can be explained by 
the inhibition of  the isoprenylation process. 
Taken together, our microarray experiments performed 
on HBx-transgenic mice have provided new mechanisms 
for HBx-mediated inhibition of  liver regeneration. The 
relevance of  our results in the context of  HBV-dependent 
cell cycle inhibition, required for an efficient HBV 
replication, awaits further evaluation.
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Background
The liver has a unique capacity to regenerate after partial hepatectomy (PH) 
or injury. Experimental evidence supports the hypothesis that proliferation 
of hepatocytes is responsible for liver regeneration after PH, despite the low 
replicative rate of hepatocytes in the normal liver. In a previous report we had 
shown that HBx expression inhibits liver regeneration after PH in HBx expressing 
transgenic mice. We also demonstrated a paracrine inhibitory effect of HBx on 
liver cell proliferation. Indeed, transplantation of HBx-expressing liver cells or 
injection of serum from HBx-transgenic mice into control mice is sufficient to 
inhibit liver regeneration after PH. Thus, HBx protein may act by combining the 
intracellular and paracrine effects, and inhibiting the proliferation of both infected 
and uninfected liver cells in the context of liver regeneration.
Research frontiers
Hepatitis B Virus (HBV) infection is a worldwide health problem. It is estimated 
that 350 million people are chronic carriers of hepatitis B virus (HBV). According to 
the WHO, hepatitis B is responsible for 1.2 million deaths each year. Chronic HBV 
infection is a major risk factor for the development of hepatocellular carcinoma. 
The HBx protein of HBV exhibits pleiotropic effects, that modulate transcription, 
cell responses to genotoxic stress, protein degradation, cell viability and signalling 
pathways. Several studies have suggested that HBx protein of HBV, participates 
in the development of HCC, although the precise role(s) in this process remain 
unclear.
Innovations and breakthroughs
In the present report, we examined the impact of HBx on the gene expression 
profile of liver cells in HBx-expressing transgenic mice, 48 h after partial 
hepatectomy. We used cDNA microarray containing over 5 thousand mouse and 
rat cDNA elements to determine genes that are altered in the presence of reduced 
liver regeneration. By demonstrating molecular mechanisms involved in HBx-
mediated inhibition of liver regeneration, the data provides a better understanding 
of the role of the HBx protein in the physiopathology of chronic liver disease 
caused by HBV infection.
Applications 
Although these observations were made in the specific context of liver regeneration 
triggered by partial hepatectomy, they may represent an important mechanism 
of HBV-dependent liver carcinogenesis in chronic hepatitis and the associated 
stimulation of liver cell proliferation. Thus, this study may contribute to the 
development of new approaches based on controlling the cellular effects of viral 
replication and ultimately provide new tools to control HBV-induced liver disease.
Peer review
This is a well written, interesting report on gene modulation associated with 
inhibition of liver regeneration in hepatitis B x protein transgenic mice.
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